ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,182.16
-0.11%
Dow Jones
38,966.98
0.21%
US Dollar vs MXN
16.90695
0.00%
Brent Oil
83.22
0.43%
Bitcoin
62,382.34
0.08%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Medicenna Therapeutics Corporation (MDNA)

  7. Medicenna Therapeutics Corporation (MDNA) Noticias

MDNA Medicenna Therapeutics Corporation

0.157
0.00 (0.00%)
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Medicenna Therapeutics Corporation MDNA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 0.157 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.157
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202414:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/4/202414:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/4/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/4/202415:40EDGAR2Form AW - Amendment Withdrawal Request
16/4/202416:05EDGAR2Form S-8 POS - Securities to be offered to employees in..
16/4/202416:05EDGAR2Form F-3/A - Registration statement by foreign private..
16/4/202416:04EDGAR2Form F-10POS - Post-effective amendment to a F-10EF..
09/4/202413:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/4/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202415:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202409:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/1/202408:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/12/202313:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202307:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
08/11/202309:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202306:00GLOBEMedicenna Announces Promising Single-Agent Response and..
03/11/202311:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
27/10/202306:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
25/10/202314:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202306:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
24/10/202306:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202306:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
10/10/202307:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202306:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
03/10/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/10/202306:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
28/9/202316:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202316:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
28/9/202309:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202306:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
06/9/202306:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/9/202306:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
28/8/202315:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202315:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/8/202306:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
14/8/202315:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/8/202306:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
09/8/202316:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/8/202308:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/8/202306:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
04/8/202307:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/8/202306:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
01/8/202311:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/8/202308:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
28/7/202307:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/7/202306:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
25/7/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/7/202306:00GLOBEMedicenna Presents at National Brain Tumor Society's..
06/7/202309:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Su Consulta Reciente

NASDAQ
MDNA
Medicenna Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados